On September 26 and 27, Harvard Law School hosted the “Innovation, Justice and Globalization” conference.
This panel “Non-voluntary licensing of pharmaceutical patents–assessing the post-Doha Declaration TRIPs system,” chaired by Justin Hughes, Loyola Marymount University, featured talks by:
Fred Abbott
Law and its limitations in global public health: Non-voluntary patent licensing post-Doha
Brook Baker
Isn’t it time for a compulsory licensing facility?
Kat Geddes
Could Compulsory Licensing Finally End the HIV Epidemic? Struggles
Over Access to Gilead’s PreP
Henning Grosse Ruse-Khan
TRIPS enforcement flexibilities – a real alternative to compulsory licensing?
Jayashree Watal
Special Compulsory Licenses for Exports: -why has it not been used much?
The conference focused on six themes: the economics of innovation and development; whether antitrust and competition law trust intellectual property law too much; the “puzzles” of overlapping and hybrid intellectual property rights; the World Trade Organization’s Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) and the role of intellectual property rights in developing countries; challenges facing the digital commons; non-voluntary licensing of pharmaceutical patents; and property rights versus liability rules — theories and practical implications. Panelists included experts from government and international/inter-governmental organizations, as well as faculty from the Harvard Business School, Harvard Law School and the Harvard Kennedy School of Government.
